Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Fort Lauderdale, FL
SEC filing record 1 source field available
Fiscal year end
31 December
Sunshine Biopharma Inc. has filed 405 SEC EDGAR filings since 25 May 2007

SEC filing history

Showing 76-100 of 374 matching filings.

Per page
25
Current page
4
NT 10-Q File 001-41282

REQUEST FOR EXTENSION

Filing date
14 Aug 2024
Reporting date
30 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14C File 001-41282

DEFINITIVE PROXY

Filing date
11 Jul 2024
Reporting date
28 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14C File 001-41282

FORM PRE 14C

Filing date
01 Jul 2024
Reporting date
01 Jul 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-41282

CURRENT REPORT

Filing date
11 Jun 2024
Reporting date
11 Jun 2024
Next action
Verify source filing
10-Q File 001-41282

FORM 10-Q FOR MARCH 2024

Filing date
20 May 2024
Reporting date
31 Mar 2024
Next action
Verify source filing
NT 10-Q File 001-41282

EXTENSION

Filing date
15 May 2024
Reporting date
31 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-41282

CURRENT REPORT

Filing date
01 Apr 2024
Reporting date
01 Apr 2024
Next action
Verify source filing
10-K File 001-41282

FORM 10-K FOR FYE END DEC 2023

Filing date
28 Mar 2024
Reporting date
31 Dec 2023
Next action
Verify source filing
DEF 14C File 001-41282

DEFINITIVE INFORMATION STATEMENT

Filing date
15 Mar 2024
Reporting date
20 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14C File 001-41282

PRELIMINARY INFORMATION STATEMENT

Filing date
05 Mar 2024
Reporting date
05 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
05 Mar 2024
Reporting date
04 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14C File 001-41282

FORM DEF 14C

Filing date
05 Mar 2024
Reporting date
08 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-85054

SCHEDULE 13G

Filing date
23 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-85054

SCHEDULE FILED TO REPORT ACQUISTION OF BENEFICAL OWNERSHIP

Filing date
21 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14C File 001-41282

PRE 14C

Filing date
21 Feb 2024
Reporting date
21 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .